AUTHOR=Abu-Raya Bahaa , Madhi Shabir A. , Omer Saad B. , Amirthalingam Gayatri , Giles Michelle L. , Flanagan Katie L. , Zimmermann Petra , O’Ryan Miguel , Safadi Marco A. , Papaevangelou Vassiliki , Maertens Kirsten , Wanlapakorn Nasamon , Diaz-Brito Vicens , Tommelein Eline , Esposito Susanna TITLE=Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders JOURNAL=Frontiers in Immunology VOLUME=12 YEAR=2021 URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.808064 DOI=10.3389/fimmu.2021.808064 ISSN=1664-3224 ABSTRACT=

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with a higher risk for severe morbidity and mortality when compared with infection in non-pregnant women of childbearing age. An increasing number of countries recommend immunization against SARS-CoV-2 in pregnant women. Recent studies provide preliminary and supportive evidence on safety, immunogenicity and effectiveness of coronavirus disease 2019 (COVID-19) vaccines in pregnant women; however, important knowledge gaps remain which warrant further studies. This collaborative consensus paper provides a review of the current literature on COVID-19 vaccines in pregnant women, identifies knowledge gaps and outlines priorities for future research to optimize protection against SARS-CoV-2 in the pregnant women and their infants.